PPIB and dementia: In epidemiological cohorts assessing patients without dementia using amyloid PET status or CSF profile, Aβ pathology was associated with APOE genotype, presence of cognitive impairment and suggested a 2- to 30- year interval between first development of Αβ positivity and onset of dementia [3, 169].